Abnormal involuntary movement scale in tardive dyskinesia: Minimal clinically important difference
Sign Up to like & getrecommendations! Published in 2019 at "Movement Disorders"
DOI: 10.1002/mds.27769
Abstract: A minimal clinically important difference has not been established for the Abnormal Involuntary Movement Scale in patients with tardive dyskinesia. Valbenazine is a vesicular monoamine transporter 2 inhibitor approved for the treatment of tardive dyskinesia… read more here.
Keywords: movement; abnormal involuntary; movement scale; involuntary movement ... See more keywords